Japan Intellectual Property Rights: HBV VACCINES AND METHODS FOR TREATING HBV

Japan, Oct. 5 -- GILEAD SCIENCES INC has got intellectual property rights for 'HBV VACCINES AND METHODS FOR TREATING HBV.' Other related details are as follows:

Application Number: JP,2025-051805

Category (FI): A61K35/76,A61K35/761,A61K35/763,A61K35/766,A61K38/43,A61K39/00@H,A61K39/29,A61K39/395@U,A61K45/00,A61K47/62,A61K48/00,A61P1/16,A61P31/14,A61P37/04,A61P43/00,121,C07K14/02,C07K14/175,C07K19/00,C12N1/15,C12N1/19,C12N1/21,C12N15/11@Z,C12N15/34,C12N15/62@Z,C12N15/63@Z,C12N15/86@Z,C12N15/88@Z,C12N15/90@Z,C12N5/10

Stage: Grant (IP right granted following substantive examination.)

Filing Date: March 26, 2025

Publication Date: June 19, 2025

The original document can be viewed at: https://www.j-platpat.inpit.go.jp/p0100

Disclaimer: Curated by HT Syndication.